There were significant differences between the two groups in age, interval to tumor diagnosis, histology of lung cancer, lung cancer grade, lung cancer T stage, histological type of breast cancer, HER2 expression status, and history of breast cancer chemotherapy. This evidence concerns the gene ERBB2 and neoplasm.